01 2Amneal Pharmaceuticals
02 7AstraZeneca
01 2FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
02 2INJECTABLE; SUBCUTANEOUS
03 4INJECTABLE;SUBCUTANEOUS
04 1SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
01 2DISCN
02 3RX
03 4Blank
01 1BYDUREON
02 1BYDUREON BCISE
03 1BYDUREON PEN
04 4BYETTA
05 2EXENATIDE SYNTHETIC
01 9USA
Regulatory Info :
Registration Country : USA
Brand Name : EXENATIDE SYNTHETIC
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300MCG/1.2ML (250MCG/ML)
Packaging :
Approval Date :
Application Number : 206697
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : EXENATIDE SYNTHETIC
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 600MCG/2.4ML (250MCG/ML)
Packaging :
Approval Date :
Application Number : 206697
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BYETTA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300MCG/1.2ML (250MCG/ML)
Packaging :
Approval Date : 2005-04-28
Application Number : 21773
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BYETTA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 600MCG/2.4ML (250MCG/ML)
Packaging :
Approval Date : 2005-04-28
Application Number : 21773
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BYETTA
Dosage Form : INJECTABLE; SUBCUTANEOUS
Dosage Strength : 300UGM/1.2ML (250UGM/ML)
Packaging :
Approval Date :
Application Number : 21919
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BYETTA
Dosage Form : INJECTABLE; SUBCUTANEOUS
Dosage Strength : 600UGM/2.4ML (250UGM/ML)
Packaging :
Approval Date :
Application Number : 21919
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BYDUREON
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
Dosage Strength : 2MG/VIAL
Packaging :
Approval Date : 2012-01-27
Application Number : 22200
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BYDUREON PEN
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
Dosage Strength : 2MG
Packaging :
Approval Date : 2014-02-28
Application Number : 22200
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BYDUREON BCISE
Dosage Form : SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
Dosage Strength : 2MG/0.85ML (2MG/0.85ML)
Packaging :
Approval Date : 2017-10-20
Application Number : 209210
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?